Cardiovascular Risk Clinical Trials in Berlin
4 recruitingBerlin, Germany
Showing 1–4 of 4 trials
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Phase 2
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Cardiovascular DiseaseCardiovascular Risk FactorChronic Kidney Disease Requiring Chronic Dialysis+2 more
Charite University, Berlin, Germany50 enrolled1 locationNCT06225544
Recruiting
Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach
Immune SystemGut MicrobiomeTransgender+1 more
Charite University, Berlin, Germany200 enrolled1 locationNCT05334888